Full Text View
Tabular View
No Study Results Posted
Related Studies
EPO906 Plus Radiation Therapy for the Treatment of Cancer Patients
This study has been completed.
Study NCT00328458   Information provided by Thomas Jefferson University

First Received on May 19, 2006.   Last Updated on March 11, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Central Nervous System Neoplasms
Head and Neck Neoplasms
Additional conditions recognized in this trial
Neoplasms
Nervous System Neoplasms
More general conditions related to this trial
Neoplasms by Site
Nervous System Diseases
Interventions listed in this trial
EPO906 (epothilone B)
Additional drug interventions recognized in this trial
Epothilone B
Epothilones
More general drug interventions related to this trial
Antimitotic Agents
Antineoplastic Agents
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
Thomas Jefferson University
Novartis Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services